Tech Company Financing Transactions
Bullet Biotechnology Funding Round
Bullet Biotechnology, based in Redwood City, scored $1.1 million from private investors.
Transaction Overview
Company Name
Announced On
7/12/2013
Transaction Type
Venture Equity
Amount
$1,135,198
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2686 Middlefield Rd. D
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Bullet Bio was founded in September 2011 with the mission to help patients fight disease by developing highly targeted immunotherapies. Bullet Capsids are hollow, non-infectious nanoparticles made from proteins.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Willie Quinn
Chief Operating Officer
Mark Robbins
Chief Scientific Officer
Thomas Theriault
Browse more venture capital transactions:
Prev: 7/12/2013: Cynvenio Biosystems venture capital transaction
Next: 7/12/2013: MetricStream venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs